Geron sees trial start in 2010 third quarter

Geron Corporation of Menlo Park California, US expects to begin its first-in-man study of a new embryonic stem cell therapy for spinal cord injury in the third quarter of 2010. This follows discussions with the Food and Drug Administration during which a strategy was outlined for lifting the trial hold.

Location